ArticleGigaScience2026
A preregistered, open pipeline for early cerebral palsy risk assessment from infant videos.
Article in GigaScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A preregistered, open pipeline for early cerebral palsy risk assessment from infant videos.GigaScience · 2026Article
Corrections and comments
- Update of
Authors and funding
5 authors.
Funding
Abstract
Cerebral palsy (CP), affecting approximately 1 in 500 children due to abnormal brain development, impacts movement control. Early risk assessment via the general movements assessment (GMA) at 3-4 months is highly predictive for CP but relies on trained clinicians. Machine-learning-based approaches for predicting GMA score from video have shown considerable promise, but typically rely on dataset-specific preprocessing, custom feature sets, and manually designed model pipelines, which make external benchmarking more difficult. This, combined with strict privacy constraints on sharing data, makes it challenging to train and evaluate models across datasets, which is important for assessing clinical utility. There is therefore a need to develop approaches that will work across different datasets to enable multi-site dataset aggregation and model training. To address this gap, we developed an end-to-end pipeline that uses off-the-shelf pose estimation, general-purpose feature extraction, and automated machine learning-none of which are tuned to a specific dataset. We applied this approach to a newly generated large dataset of 1053 infants (with approximately 10-12% positive class for adverse GMA outcome, drawn from a high-risk clinical cohort) within a preregistered study design. Model performance was evaluated on a strict "lock-box" test set, which remained untouched during any phase of model development or preprocessing optimization, and only used for evaluation once the final model and pipeline had been preregistered. The developed model achieved moderate predictive accuracy for clinician-assessed GMA scores (area under the receiver operating characteristic curve, ROC-AUC = 0.77; area under the precision-recall curve, PR-AUC = 0.41). The moderate accuracy is noteworthy given the 10-12% positive class prevalence, and power-law scaling of ROC-AUC as a function of increasing dataset size. By releasing de-identified feature data and open-source code, and simplifying the training pipeline using AutoML, our work establishes essential groundwork for future robust, globally relevant CP screening tools suitable for low-resource settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.